Search

Your search keyword '"Hashimoto, Eri"' showing total 299 results

Search Constraints

Start Over You searched for: Author "Hashimoto, Eri" Remove constraint Author: "Hashimoto, Eri"
299 results on '"Hashimoto, Eri"'

Search Results

3. A Case of Fish Sausage Anaphylaxis Induced by Epicutaneous Sensitization to Carmine Contained in Eyeshadows: The Effect of Chelation on Carmine Allergy.

5. Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments

8. Contributors

10. Consensus paper of the WFSBP task force on biological markers: Biological markers for alcoholism

11. Soft x-ray photoelectron momentum microscope for multimodal valence band stereography

13. FIGURE 5 from Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

14. Table S3 from Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

15. FIGURE 3 from Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

16. Tumor-infiltrating leukocyte profiling defines three immune subtypes of NSCLC with distinct signaling pathways and genetic alterations

17. Supplementary Figure 7 from Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression

18. Supplementary Information from Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression

19. Data from Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression

20. Supplementary Figure 2 from Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression

21. Supplementary Figure 3 from Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression

22. Supplementary Figure 5 from Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression

23. Supplementary Figure 6 from Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression

24. Supplementary Figure 1 from Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression

25. Supplementary Figure 4 from Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating EGFR Mutations and HGF Overexpression

45. Characterization of epitaxial CVD graphene on Ir(111)/ α -Al2O3(0001) by photoelectron momentum microscopy.

Catalog

Books, media, physical & digital resources